Sexual Health
PT-141
Starting at $249/month*
A melanocortin-targeting peptide studied for supporting sexual desire and arousal in both men and women — acting through the nervous system rather than blood flow.
- Supports desire & arousal
- Works through the nervous system
- For men and women
- Licensed-provider care, shipped discreetly
*Price reflects the longest available treatment plan. Prescription therapies require an online consultation and licensed-provider approval. Compounded for research-informed wellness use under licensed-provider guidance.
How It Works
PT-141 (bremelanotide) is a peptide that activates melanocortin receptors in the central nervous system. Unlike treatments that target blood flow, it is studied for influencing the brain pathways involved in sexual desire and arousal, used under provider guidance.
Discovery & Testing Background
PT-141 was developed from research into melanocortin peptides. A formulation of bremelanotide has been FDA-approved for low sexual desire in premenopausal women, and the peptide continues to be studied for sexual wellness in men and women.
Potential Side Effects
Reported effects may include temporary nausea, flushing, headache, or injection-site irritation. PT-141 is used under provider guidance, and your provider will review whether it is appropriate for you.
PT-141 Benefits
Function: PT-141 is studied for activating melanocortin receptors involved in sexual desire and arousal, working centrally rather than through the vascular system.
Benefit: This has made it popular among those seeking provider-guided support for libido and sexual wellness — including when blood-flow-based options are not a fit.
